Senti Biosciences, Inc. financial data

Symbol
SNTI on Nasdaq
Location
2 Corporate Drive, First Floor, South San Francisco, CA
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2025 - Aug 7, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 359 % -40.5%
Debt-to-equity 171 % +124%
Return On Equity -224 % -28.1%
Return On Assets -76 % +23.4%
Operating Margin -27.3K % -1781%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 26.2M shares +471%
Common Stock, Shares, Outstanding 26.2M shares +472%
Entity Public Float 10.8M USD -54%
Common Stock, Value, Issued 3K USD +200%
Weighted Average Number of Shares Outstanding, Basic 26.1M shares +470%
Weighted Average Number of Shares Outstanding, Diluted 26.1M shares +470%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 0 USD -100%
Revenue from Contract with Customer, Excluding Assessed Tax 0 USD -100%
Research and Development Expense 35.7M USD -1.13%
General and Administrative Expense 28.5M USD -6.35%
Operating Income (Loss) -64.6M USD +30%
Nonoperating Income (Expense) 6.26M USD -54%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -58.3M USD +46.6%
Earnings Per Share, Basic -8 USD/shares +46%
Earnings Per Share, Diluted -8 USD/shares +46%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 21.6M USD +36%
Cash, Cash Equivalents, and Short-term Investments 35.9M USD -63.6%
Accounts Receivable, after Allowance for Credit Loss, Current 567K USD
Other Assets, Current 0 USD -100%
Assets, Current 32.5M USD -26.7%
Property, Plant and Equipment, Net 19.6M USD -15.7%
Operating Lease, Right-of-Use Asset 12.8M USD -16.1%
Other Assets, Noncurrent 52K USD -31.6%
Assets 68.5M USD -21.1%
Accounts Payable, Current 1.02M USD -13.6%
Employee-related Liabilities, Current 1.49M USD +10.6%
Contract with Customer, Liability, Current 0 USD -100%
Liabilities, Current 9.99M USD +10.1%
Operating Lease, Liability, Noncurrent 26.3M USD -15.9%
Other Liabilities, Noncurrent 7.57M USD
Liabilities 43.9M USD +2.63%
Accumulated Other Comprehensive Income (Loss), Net of Tax 0 USD -100%
Retained Earnings (Accumulated Deficit) -326M USD -21.8%
Stockholders' Equity Attributable to Parent 24.7M USD -44.2%
Liabilities and Equity 68.5M USD -21.1%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -14.1M USD -20.3%
Net Cash Provided by (Used in) Financing Activities -414K USD
Net Cash Provided by (Used in) Investing Activities 0 USD
Common Stock, Shares Authorized 500M shares 0%
Common Stock, Shares, Issued 26.2M shares +472%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -14.5M USD -23.7%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 25.1M USD +29.4%
Deferred Tax Assets, Valuation Allowance 81.7M USD +33.4%
Deferred Tax Assets, Gross 85.4M USD +31.8%
Operating Lease, Liability 31.3M USD -12.1%
Depreciation 926K USD -5.89%
Payments to Acquire Property, Plant, and Equipment 0 USD -100%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -58.3M USD -2.4%
Lessee, Operating Lease, Liability, to be Paid 41.6M USD -15%
Property, Plant and Equipment, Gross 30.9M USD -0.83%
Operating Lease, Liability, Current 4.98M USD +15%
Lessee, Operating Lease, Liability, to be Paid, Year Two 5.77M USD -25.2%
Lessee, Operating Lease, Liability, to be Paid, Year One 7.71M USD +3.13%
Operating Lease, Weighted Average Discount Rate, Percent 0.09 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 10.3M USD -22.7%
Lessee, Operating Lease, Liability, to be Paid, Year Three 4.86M USD -15.8%
Deferred Tax Assets, Operating Loss Carryforwards 51M USD +51.8%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 2.38M USD +14.5%
Lessee, Operating Lease, Liability, to be Paid, Year Four 5M USD +2.99%
Additional Paid in Capital 351M USD +12.5%
Preferred Stock, Shares Outstanding 0 shares
Share-based Payment Arrangement, Expense 4M USD -22.3%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%